Patients with Lynch syndrome have an increased risk of colorectal cancer.
News
NICE backs Bayer’s Xarelto
The decision is based on evidence from the COMPASS study, which was stopped early after meeting its primary efficacy endpoint.
NHS Confederation addresses new PM over ‘unfinished business’
The NHS Confederation has penned a letter to Boris Johnson, the UK’s new prime minister.
E-theraputics, Novo Nordisk extend research collaboration
The amendment extends the original contract by six months to June 2020.
GSK completes transaction with Pfizer
GSK has a controlling equity interest of 68% and Pfizer has an equity interest of 32% in the venture.
Kisqali success continues with positive late-stage trial results
The success marks the second Phase III clinical trial in which Kisqali met overall survival.
Nubeqa bags FDA green light
The drug has been approved under the governing body’s Priority Review designation.
Eli Lilly announces Verzenio survival benefit
Breast cancer is the most common cancer in women worldwide, with more than two million new cases diagnosed in 2018.
Neuraxpharm launches first products in UK
It has also announced the appointment of the company’s new general manager, Craig Bowen.
Biodesix, Immodulon team up for pancreatic cancer treatment
The partnership will focus on the analysis of the circulating proteome of advanced pancreatic cancer patients treated with IMM-10.
RCGP warns new PM that we ‘cannot risk no-deal disruption’
Johnson also took a moment in his speech to announced that he wants to revisit and potentially reverse the sugar tax.
£3m funding for MS, Parkinson’s
The money will go to a new UK ‘digital brain bank’, Europe’s largest brain and tissue bank, based in London.
52 cases of malaria reported in Scotland
The figure is an increase of 4% from the 2017 total.
IONTAS, Teva announce new antibody optimisation agreement
Teva recently halted its Ajovy clinical development.
EMA positive opinion granted for Keytruda combo
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorisation.
